About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UNKNOWNPhase 2/3

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

NCT04327791•Bassett Healthcare

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Influenza

Interventions

Baloxavir

Placebos

Locations

3

United States

Locations (3)

Baystate Medical Center

Springfield, Massachusetts, United States

Bassett Medical Center

Cooperstown, New York, United States

Oregon Health & Science University

Portland, Oregon, United States

Key Dates

Start Date

April 3, 2020

Primary Completion Date

June 1, 2024

Completion Date

June 1, 2025

Last Updated

October 30, 2023

Related Studies

RECRUITINGPhase 1/2

Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

NCT07291635

RECRUITINGPhase 3

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

NCT06094010

Dime La VerDAD: Verify, Debunk, and Disseminate

NCT06417762

InfluenzaCOVID-19+3 more

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

NCT06160128

COVID-19, SARS-CoV-2 InfectionRSV+1 more

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

NCT07396428

Acute Respiratory InfectionInfluenza-like Illness

Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility

NCT07310472

Influenza Vaccination

View all related studies

Contacts

jennifer Victory, RN

CONTACT

6075476965 jennifer.victory@bassett.org

Daniel Freilich, MD

CONTACT

6075474586 daniel.freilich@bassett.org

Sponsors

Lead Sponsor

Bassett Healthcare

Collaborators

Genentech, Inc.
Viroclinics Biosciences B.V.

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 30, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions